Experimental Study on Assessment of Gene Therapy in Chronic Myocardial Ischemia by Strain Rate Imaging and Doppler Tissue Imaging

QIAN Rong,ZHAO Bao-zhen,XU Jing,WANG wei,GU Li-min

DOI: https://doi.org/10.3760/j.issn:1004-4477.2005.05.014

2005-01-01

Abstract:Objective To investigate the value of strain rate imaging and Doppler tissue imaging in detecting chronic myocardial ischemia before and after gene therapy. Methods Sixteen pigs were employed to build up the chronic myocardial ischemia model by placing ameroid constrictors on the proximal of the left circumflex coronary artery. Four weeks later, therapy group and control group were intramyocardially administrated recombinant adenovirus coding the vascular endothelial growth factors(Ad.VEGF-B) or phosphate buffer. Then after 4 weeks, their hearts were removed for pathological investigation. Pre-operation, 2 and 4 weeks after ameroid placement and 2 and 4 weeks after gene therapy, V S,V E,V A and myocardial velocity gradient(MVG) of lateral-posterior wall from short-axis view at the level of papillary muscles were measured. Results Compared with pre-operation, the V S and V E of lateral-posterior wall of the left ventricle slightly reduced without statistical significance 2 weeks after operation, but the MVG decreased significantly(P(0.05)); Till 4 weeks, the V S and V E also significantly decreased(P(0.05)) and the regional wall thinned. Two weeks after gene therapy, the myocardial velocity estimated by Doppler tissne imaging did not change in the therapy group and the control group, but MVG was significantly higher than that in control subjects(P(0.05)); Four weeks post-therapy, V E of the therapy group was notably higher than that of the control group(P(0.05)) and the MVG further increased(P(0.05)). Conclusions The MVG and the velocity of myocardial motion can accurately detect changes of the wall thickness and velocity of regional ventricular wall motion in ischemic myocardium before and after gene therapy,the MVG is a more sensitive indicator of quantitative assessment of the regional myocardial function.